Effects of pulmonary rehabilitation on dyspnea, exercise capacity and health status in patients with idiopathic pulmonary fibrosis.
Not Applicable
- Conditions
- idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000002309
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with collagen vascular disease, occupational lung disease, sarcoidosis, hypersensitivity pneumonitis and other idiopathic interstitial pneumonias were excluded. Others were MRC grade 5, severe orthopedic or neurological disorders limiting exercise performance, unstable cardiac disease, inability to understand or complete questionnaires and previous participation in a pulmonary rehabilitation program.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pulmonary rehabilitation benefits in IPF patients?
How does pulmonary rehabilitation compare to antifibrotic drugs in IPF treatment outcomes?
Which biomarkers predict response to pulmonary rehabilitation in IPF and COPD patients?
What adverse events are associated with pulmonary rehabilitation in IPF patients and how are they managed?
Are there combination therapies that enhance pulmonary rehabilitation effects in IPF patients?